The exposure rate constant for a silver wire 125I seed

Area of Science:

• Medical Physics
• Nuclear Medicine
• Radiotherapy

Background:

• The development of new brachytherapy seeds is crucial for advancing radiation oncology treatments.
• Iodine-125 (125I) seeds are widely used in brachytherapy due to their favorable dosimetry characteristics.
• Comparing the physical properties of novel seed designs with established ones is essential for clinical adoption.

Purpose of the Study:

• To characterize the physical properties of a new silver wire 125I seed.
• To compare these properties with the original gold sphere 125I seed.
• To evaluate the implications for clinical use in brachytherapy.

Main Methods:

• Measurement of physical characteristics using a scintillation spectrometer.
• Determination of the exposure rate constant.
• Calculation of photon-fluence rate and exposure rate.
• Analysis of angular intensity distribution and anisotropy factor.

Main Results:

• The measured exposure rate constant for the silver wire 125I seed is 1.361 R cm2/mCi h, closely matching the theoretical value.
• This value is comparable to the previously reported 1.309 R cm2/mCi h for the gold sphere 125I seed.
• Angular intensity distribution and anisotropy factor are similar between the silver wire and gold sphere 125I seeds.

Conclusions:

• The physical characteristics of the silver wire 125I seed are highly similar to the gold sphere 125I seed.
• No changes are anticipated in the clinical application of these two types of 125I seeds.
• The findings support the continued use and potential adoption of the silver wire 125I seed in brachytherapy.